Ormat Technologies, Inc. (ORA)

Elevation Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,298	4,097	4,574	4,850	4,441	5,041
Market Cap Growth	17.29%	-10.44%	-5.69%	9.22%	-11.91%	32.66%
Enterprise Value	7,941	6,567	6,652	6,887	6,229	6,467
PE Ratio	40.43	33.11	36.77	73.67	71.52	58.99
PS Ratio	5.84	4.66	5.52	6.61	6.70	7.15
PB Ratio	2.13	1.60	1.87	2.39	2.21	2.58
P/OCF Ratio	-	9.97	14.78	17.26	17.16	19.02
EV/Sales Ratio	8.76	7.47	8.02	9.38	9.39	9.17
EV/EBITDA Ratio	17.57	14.90	16.95	18.42	17.13	18.25
EV/EBIT Ratio	47.38	38.62	41.22	40.53	35.23	33.24
Debt / Equity Ratio	1.04	0.96	0.86	1.01	0.96	0.76
Debt / EBITDA Ratio	5.88	5.41	5.24	5.33	5.19	4.13
Quick Ratio	0.40	0.56	0.87	0.79	0.80	2.57
Current Ratio	0.70	0.92	1.20	1.33	1.11	3.13
Asset Turnover	0.16	0.16	0.17	0.16	0.16	0.20
Return on Equity (ROE)	5.30%	5.24%	5.94%	3.85%	3.84%	5.86%
Return on Assets (ROA)	1.82%	1.95%	2.05%	2.35%	2.66%	3.41%
Return on Capital (ROIC)	2.04%	2.22%	2.33%	2.65%	2.99%	3.90%
Return on Capital Employed (ROCE)	3.20%	3.40%	3.50%	4.00%	4.60%	5.30%
Earnings Yield	2.48%	3.02%	2.72%	1.36%	1.40%	1.70%
Earnings Yield	2.48%	3.02%	2.72%	1.36%	1.40%	1.70%
FCF Yield	-	-1.87%	-6.75%	-5.82%	-3.61%	-1.11%
Dividend Yield	0.55%	0.71%	0.64%	0.56%	0.62%	0.51%
Payout Ratio	22.22%	23.53%	22.84%	41.23%	43.46%	26.30%
Buyback Yield / Dilution	-0.51%	-1.72%	-5.77%	-0.18%	-8.60%	-1.39%
Total Shareholder Return	0.04%	-1.01%	-5.13%	0.39%	-7.98%	-0.87%

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.

SEC Filings: 10-K · 10-Q